P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia
Article in Nature Cancer (June 2022)
The most recent citing publications are shown below. View all 183 publications that cite this research output on Dimensions.
Article in Nature Cancer (June 2022)
Article in European Journal of Medical Genetics (April 2022)
Article in PLOS ONE (April 2022)